Pridinol Mesilate

Centrally acting muscle relaxant with anticholinergic effects.

At last update no published on excretion in breast milk data were found. Even on humans pharmacokinetic data is barely found.

Its anticholinergic effect has a theoretical risk of inhibiting lactation especially during the early postpartum weeks.

Until more data about this drug regarding breastfeeding is available, safer known alternatives should be of choice, especially in the neonatal period and in case of prematurity.

If administered during breastfeeding, use small doses and monitor drowsiness and adequate feeding of the infants.

(Not to be confused with the trademark Pridinol, which in some countries corresponds to Terfenadine)

Alternatives

• Baclofen (Very Low Risk)
• Methocarbamol (Low Risk probable)